PubHive wins UK niche literature software award for 2026

By AI, Created 12:51 PM UTC, June 04, 2026, /AGP/ – PubHive was named Best Niche Literature Software Company 2026 – UK by the Acquisition International Global Excellence Awards. The recognition spotlights the company’s AI-powered literature workflows for life sciences teams that need faster evidence review, better traceability, and audit-ready compliance support.

Why it matters: - Life sciences teams are facing more publication volume and tighter regulatory expectations. - PubHive’s platform is aimed at helping pharmaceutical, biotechnology, medical device, and other regulated teams manage evidence work with more structure and traceability. - The award underscores demand for software that can connect literature monitoring, review, and documentation across safety, regulatory, and medical functions.

What happened: - PubHive was named “Best Niche Literature Software Company 2026 – UK” at the Acquisition International Global Excellence Awards 2026. - The award recognizes PubHive’s AI-powered scientific literature and safety workflow solutions. - PubHive said the honor reflects its focus on helping life sciences organizations manage scientific literature in a practical, traceable, and compliance-aware way.

The details: - PubHive Navigator™, the company’s flagship platform, supports literature monitoring, AI-assisted screening, pharmacovigilance review, medical affairs intelligence, regulatory evidence workflows, medical device literature review, document delivery, citation structuring, and knowledge reuse. - The platform also supports pharmacovigilance, drug safety, ICSR review, signal detection, aggregate safety reporting, quality control, and local literature workflows. - PubHive says the system helps teams move away from fragmented manual processes, inbox-based alerts, spreadsheets, and disconnected tools. - The company says the platform is built around connected, explainable, and audit-ready evidence workflows. - PubHive says its approach combines intelligent automation with structured human review, configurable workflows, and audit-ready traceability. - PubHive Navigator is positioned for pharmacovigilance, medical affairs, regulatory, clinical, medical device, R&D, medical writing, library, and knowledge management teams. - Supported use cases include scientific literature monitoring and screening, pharmacovigilance literature review and safety workflows, medical affairs intelligence and evidence management, medical device CER, PMCF, and post-market literature workflows, regulatory and clinical literature review, document delivery, citation matching, metadata enrichment, AI-assisted summaries, tagging, classification, decision support, and audit-ready documentation. - PubHive said the platform helps organizations turn scientific information into structured, reusable, and defensible knowledge. - The company lists more information on its website and demo access for prospective customers.

Between the lines: - The award signals a broader shift in life sciences software toward evidence intelligence rather than basic literature search. - PubHive is framing AI as a support layer for expert judgment, not a replacement for regulated review processes. - The company is emphasizing workflow integration, reuse of evidence, and documentation quality as its key differentiators.

What’s next: - PubHive says it will keep investing in AI-powered workflows for literature monitoring, pharmacovigilance, medical affairs, regulatory intelligence, medical device evidence management, document delivery, citation structuring, signal detection, and safety operations. - PubHive Navigator is expected to continue evolving as the company pushes organizations toward connected, structured, workflow-ready evidence intelligence. - PubHive invites media inquiries at hello@pubhive.com.